News
China’s drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
7h
The Print on MSNBlockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunityPharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and ...
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...
Detailed price information for Restaurant Brands International (QSR-N) from The Globe and Mail including charting and trades.
U.S. stocks closed rallied on Friday, with the Nasdaq Composite (COMP:IND) securing another back-to-back record, even as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results